4DMedical Ltd
ASX:4DX

Watchlist Manager
4DMedical Ltd Logo
4DMedical Ltd
ASX:4DX
Watchlist
Price: 1.9 AUD 3.26% Market Closed
Market Cap: 972.1m AUD

4DMedical Ltd
Gross Profit

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

4DMedical Ltd
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
4DMedical Ltd
ASX:4DX
Gross Profit
AU$5.4m
CAGR 3-Years
168%
CAGR 5-Years
117%
CAGR 10-Years
N/A
Mach7 Technologies Ltd
ASX:M7T
Gross Profit
AU$32.6m
CAGR 3-Years
8%
CAGR 5-Years
15%
CAGR 10-Years
99%
CogState Ltd
ASX:CGS
Gross Profit
$32.1m
CAGR 3-Years
7%
CAGR 5-Years
28%
CAGR 10-Years
20%
Pro Medicus Ltd
ASX:PME
Gross Profit
AU$220.2m
CAGR 3-Years
33%
CAGR 5-Years
31%
CAGR 10-Years
29%
Alcidion Group Ltd
ASX:ALC
Gross Profit
AU$36m
CAGR 3-Years
7%
CAGR 5-Years
49%
CAGR 10-Years
N/A
A
Artrya Ltd
ASX:AYA
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

4DMedical Ltd
Glance View

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-08-07. The firm is focused on development of a non-invasive respiratory imaging solution using four-dimensional imaging. The firm's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. The company enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.

4DX Intrinsic Value
0.32 AUD
Overvaluation 83%
Intrinsic Value
Price

See Also

What is 4DMedical Ltd's Gross Profit?
Gross Profit
5.4m AUD

Based on the financial report for Jun 30, 2025, 4DMedical Ltd's Gross Profit amounts to 5.4m AUD.

What is 4DMedical Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
117%

Over the last year, the Gross Profit growth was 53%. The average annual Gross Profit growth rates for 4DMedical Ltd have been 168% over the past three years , 117% over the past five years .

Back to Top